Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EHHADH encodes the peroxisomal bifunctional enzyme, which catalyzes two sequential steps in the β-oxidation of fatty acids within peroxisomes—the hydration of enoyl-CoA into 3-hydroxyacyl-CoA and the subsequent dehydrogenation to 3-ketoacyl-CoA. The enzyme is essential for the metabolism of straight-chain and dicarboxylic fatty acids, particularly during fasting, where it is indispensable for the production of medium-chain dicarboxylic acids (e.g., adipic and suberic acid) and their carnitine esters. EHHADH activity is highly inducible by PPARα agonists such as fibrates and is critical for energy generation from fatty acids in the liver. Genetic defects in EHHADH are implicated in peroxisomal disorders like Zellweger syndrome, and alterations in its expression or activity may influence glucose metabolism and contribute to metabolic and renal diseases. The enzyme acts as a trifunctional protein with additional isomerase activity, handling a variety of β-oxidation substrates, and participates in coordinated metabolic responses to fasting and peroxisome proliferator drugs.
Activation by PPARα agonists, which induce enzyme expression and activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal bifunctional enzyme (enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase) (EHHADH).